Kathryn E. Wengel - Feb 14, 2022 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
EVP, Chief GSC Officer
Signature
Raavi K. Deol, as attorney-in-fact for Kathryn E. Wengel
Stock symbol
JNJ
Transactions as of
Feb 14, 2022
Transactions value $
-$117,351
Form type
4
Date filed
2/15/2022, 07:03 PM
Previous filing
Feb 15, 2022
Next filing
Mar 29, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JNJ Common Stock Options Exercise $0 +1.9K +2.94% $0.00 66.3K Feb 14, 2022 Direct F1
transaction JNJ Common Stock Tax liability -$117K -695 -1.05% $168.85 65.6K Feb 14, 2022 Direct F2
holding JNJ Common Stock 46 Feb 14, 2022 By 401k F3
holding JNJ Common Stock 281 Feb 14, 2022 By ESOP F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Restricted Share Units Options Exercise $0 -1.9K -100% $0.00* 0 Feb 14, 2022 Common Stock 1.9K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 11, 2019; converted into shares of Common Stock upon vesting.
F2 Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F3 Includes shares accrued due to dividend reinvestment in the Johnson & Johnson Stock Fund under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).
F4 Shares held by ESOP under the Johnson & Johnson Savings Plan as of the Plan's most recent reporting date (1/31/2022).